85 related articles for article (PubMed ID: 16556714)
21. Is empirical radioactive iodine therapy still a valid approach to patients with thyroid cancer and elevated thyroglobulin?
Rosario PW; Mourão GF; dos Santos JB; Calsolari MR
Thyroid; 2014 Mar; 24(3):533-6. PubMed ID: 24067080
[TBL] [Abstract][Full Text] [Related]
22. Papillary thyroid carcinoma metastatic to the pituitary gland.
Masiukiewicz US; Nakchbandi IA; Stewart AF; Inzucchi SE
Thyroid; 1999 Oct; 9(10):1023-7. PubMed ID: 10560958
[TBL] [Abstract][Full Text] [Related]
23. Central hypothyroidism associated with retinoid X receptor-selective ligands.
Sherman SI; Gopal J; Haugen BR; Chiu AC; Whaley K; Nowlakha P; Duvic M
N Engl J Med; 1999 Apr; 340(14):1075-9. PubMed ID: 10194237
[TBL] [Abstract][Full Text] [Related]
24. Correlation of clinicopathological features and expression of molecular markers with prognosis after ¹³¹I treatment of differentiated thyroid carcinoma.
Qin C; Cau W; Zhang Y; Mghanga FP; Lan X; Gao Z; An R
Clin Nucl Med; 2012 Mar; 37(3):e40-6. PubMed ID: 22310269
[TBL] [Abstract][Full Text] [Related]
25. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
Vassilopoulou-Sellin R; Schultz PN; Haynie TP
Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
[TBL] [Abstract][Full Text] [Related]
26. Radioiodide treatment of pulmonary metastases of differentiated thyroid cancer. Results and prognostic factors.
Nĕmec J; Zamrazil V; Pohunková D; Röhling S
Nuklearmedizin; 1979 May; 18(2):86-90. PubMed ID: 471778
[TBL] [Abstract][Full Text] [Related]
27. Use of recombinant human thyrotropin before radioiodine therapy in patients with advanced differentiated thyroid carcinoma.
Luster M; Lassmann M; Haenscheid H; Michalowski U; Incerti C; Reiners C
J Clin Endocrinol Metab; 2000 Oct; 85(10):3640-5. PubMed ID: 11061516
[TBL] [Abstract][Full Text] [Related]
28. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.
Mazzaferri EL; Robbins RJ; Spencer CA; Braverman LE; Pacini F; Wartofsky L; Haugen BR; Sherman SI; Cooper DS; Braunstein GD; Lee S; Davies TF; Arafah BM; Ladenson PW; Pinchera A
J Clin Endocrinol Metab; 2003 Apr; 88(4):1433-41. PubMed ID: 12679418
[TBL] [Abstract][Full Text] [Related]
29. [Clinical study on pulmonary metastases of differentiated thyroid carcinoma--with special reference to the extent of thyroid resection and RI therapy].
Ozaki O; Ito K; Manabe Y; Nishikawa Y; Mimura T
Nihon Geka Gakkai Zasshi; 1985 Dec; 86(12):1596-9. PubMed ID: 4088188
[TBL] [Abstract][Full Text] [Related]
30. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays.
Schlumberger M; Arcangioli O; Piekarski JD; Tubiana M; Parmentier C
J Nucl Med; 1988 Nov; 29(11):1790-4. PubMed ID: 3183748
[TBL] [Abstract][Full Text] [Related]
31. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].
Lind P; Igerc I; Kohlfürst S
Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998
[TBL] [Abstract][Full Text] [Related]
32. Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma.
Hoftijzer H; Heemstra KA; Morreau H; Stokkel MP; Corssmit EP; Gelderblom H; Weijers K; Pereira AM; Huijberts M; Kapiteijn E; Romijn JA; Smit JW
Eur J Endocrinol; 2009 Dec; 161(6):923-31. PubMed ID: 19773371
[TBL] [Abstract][Full Text] [Related]
33. Increased I-131 uptake in local recurrence and distant metastases after second treatment with retinoic acid.
Koerber C; Schmutzler C; Rendl J; Koehrle J; Griesser H; Simon D; Reiners C
Clin Nucl Med; 1999 Nov; 24(11):849-51. PubMed ID: 10551465
[TBL] [Abstract][Full Text] [Related]
34. Plasmapheresis rapidly eliminates thyroid hormones from the circulation, but does not affect the speed of TSH recovery following prolonged suppression.
Liel Y; Weksler N
Horm Res; 2003; 60(5):252-4. PubMed ID: 14614231
[TBL] [Abstract][Full Text] [Related]
35. Triiodothyronine-producing metastatic follicular thyroid carcinoma.
Hasen J; Goldiner M
Horm Res; 1977; 8(4):219-23. PubMed ID: 924359
[TBL] [Abstract][Full Text] [Related]
36. Relationship between thyrotropin stimulation and radioiodine uptake in lung metastases of differentiated thyroid carcinoma.
Schlumberger M; Charbord P; Fragu P; Gardet P; Lumbroso J; Parmentier C; Tubiana M
J Clin Endocrinol Metab; 1983 Jul; 57(1):148-51. PubMed ID: 6853672
[TBL] [Abstract][Full Text] [Related]
37. A Phase II Trial of Bexarotene for Advanced Differentiated Thyroid Cancer.
Klopper J; Kane M; Jimeno A; Sams S; French J; Pike L; Tompkins K; Haugen B
Thyroid; 2015 May; 25(5):563-4. PubMed ID: 25778496
[No Abstract] [Full Text] [Related]
38. [Research progress on clinical diagnosis for lung metastases from differentiated thyroid carcinoma].
Li H; Li S; You J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2014 Aug; 31(4):950-4. PubMed ID: 25464820
[TBL] [Abstract][Full Text] [Related]
39. Appropriate intravenous doses of L-thyroxine and magnesium in a thyroidectomized patient with thyroid and parathyroid carcinomas receiving total parenteral nutrition during acute necrotizing pancreatitis.
Sato K; Toraya S; Shiratori K; Kasagi Y; Mandai Y; Miyamoto T; Fukuda I; Kasono K; Demura H; Obara T
Intern Med; 1995 Mar; 34(3):176-82. PubMed ID: 7787323
[TBL] [Abstract][Full Text] [Related]
40. Drugs that suppress TSH or cause central hypothyroidism.
Haugen BR
Best Pract Res Clin Endocrinol Metab; 2009 Dec; 23(6):793-800. PubMed ID: 19942154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
